Clinical Trial Update: Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating switching kidney or liver transplant recipients with chronic hepatitis B to Tenofovir alafenamide therapy; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Safety Issues, Chronic Hepatitis B | Phase 4 | Status: ACTIVE_NOT_RECRUITING